Status:
COMPLETED
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
Lead Sponsor:
Mannkind Corporation
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue
Eligibility Criteria
Inclusion
- Non-smokers with clinical diagnosis of Type 2 diabetes mellitus for \>or= to 6 months
- Stable regimen of metformin for \> or = to 1000mg/day or maximum tolerated dose) and a secretagogue \< or = 1/2 the maximum manufacturer-recommended daily dose without any dose adjustments within the preceding 6 wks.
- Fixed dose combination products of metformin and sulfonylurea are acceptable as long as each individual dose meets inclusion criteria
- HbA1c \>or= to 7.5% and \< or= to 11.0%
- BMI \< or = to 40kg/m2.
- FEV1\> or = to 70%, Total Lung capacity and \> or =80% DLco \> or= to 70%
Exclusion
- Treatment with any type of anti-diabetic therapy, other than metformin \& secretagogues within the preceding 12 weeks
- Serum creatinine \> 1.4mg/dL in female subjects and \>1.5mg/dL in male subjects
- History of chronic obstructive pulmonary disease, clinically proven asthma and/or any other clinically important pulmonary function testing and/or radiologic findings
- Evidence of serious complications of diabetes (e.g. autonomic neuropathy)
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
547 Patients enrolled
Trial Details
Trial ID
NCT00332488
Start Date
December 1 2004
Last Update
October 16 2014
Active Locations (120)
Enter a location and click search to find clinical trials sorted by distance.
1
Radiant Research-Birmingham
Birmingham, Alabama, United States, 35209
2
Parkway Medical Center
Birmingham, Alabama, United States, 35215
3
Redpoint Research
Phoenix, Arizona, United States, 85029
4
Arizona Center for Clinical Research
Phoenix, Arizona, United States, 85032